GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tellgen Corp (SZSE:300642) » Definitions » Price-to-Owner-Earnings

Tellgen (SZSE:300642) Price-to-Owner-Earnings : 224.40 (As of Jun. 24, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Tellgen Price-to-Owner-Earnings?

As of today (2024-06-24), Tellgen's share price is ¥11.22. Tellgen's Owner Earnings per Share (TTM) ended in Mar. 2024 was ¥0.05. It's Price-to-Owner-Earnings for today is 224.40.


The historical rank and industry rank for Tellgen's Price-to-Owner-Earnings or its related term are showing as below:

SZSE:300642' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 36.92   Med: 60.51   Max: 303.59
Current: 207.78

During the past 12 years, the highest Price-to-Owner-Earnings of Tellgen was 303.59. The lowest was 36.92. And the median was 60.51.


SZSE:300642's Price-to-Owner-Earnings is ranked worse than
92.63% of 285 companies
in the Medical Devices & Instruments industry
Industry Median: 31.42 vs SZSE:300642: 207.78

As of today (2024-06-24), Tellgen's share price is ¥11.22. Tellgen's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.45. Therefore, Tellgen's PE Ratio for today is 24.88.

As of today (2024-06-24), Tellgen's share price is ¥11.22. Tellgen's EPS without NRI for the trailing twelve months (TTM) ended in was ¥0.50. Therefore, Tellgen's PE Ratio without NRI for today is 22.31.

During the past 12 years, Tellgen's highest PE Ratio without NRI was 59.44. The lowest was 21.25. And the median was 27.69.


Tellgen Price-to-Owner-Earnings Historical Data

The historical data trend for Tellgen's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tellgen Price-to-Owner-Earnings Chart

Tellgen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 39.30 94.07 55.05 58.90 123.43

Tellgen Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 58.82 63.23 301.56 123.43 259.63

Competitive Comparison of Tellgen's Price-to-Owner-Earnings

For the Medical Devices subindustry, Tellgen's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tellgen's Price-to-Owner-Earnings Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tellgen's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Tellgen's Price-to-Owner-Earnings falls into.



Tellgen Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Tellgen's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=11.22/0.05
=224.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tellgen  (SZSE:300642) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Tellgen Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Tellgen's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Tellgen (SZSE:300642) Business Description

Traded in Other Exchanges
N/A
Address
No. 115, Lane 572, Bibo Road, Building 1, Zhangjiang Hi-Tech Park, China (Shanghai) Pilot Free Trade Zone, Shanghai, CHN, 201203
Tellgen Corp manufactures and distributes in vitro diagnostic devices for detection of tumor. Its products include tumor marker, human papillomavirus, real time PCR, DNA methylation, autoimmune antibody, infectious disease and others. The company has developed products in the fields of tumor detection, cervical cancer screening, DNA methylation detection, male infertility and prenatal and postnatal care. Its products include tumor marker series products, human papillomavirus series products, Y chromosome microdeletion detection products, real time PCR, autoimmune antibody, and others.
Executives
Zhou Ai Guo Directors, executives
Chen Si Han Securities Affairs Representative

Tellgen (SZSE:300642) Headlines

No Headlines